Abstract

Using nationwide cohort data, this study evaluated predictors of flares in patients with rheumatoid arthritis (RA) who exhibit low disease activity (LDA) and the effects of flares on clinical outcomes. The Korean Observational Study Network for Arthritis (KORONA) registry is a nationwide Korean RA-specific cohort registry that collects data annually from 5.077 patients, with RA in 23 centers across South Korea. This study used data from 1.717 patients with RA who exhibited LDA [28–joint disease activity score (DAS28) < 3.2] at enrollment. Flares were defined as an increase in DAS28, compared with the previous value of > 1.2 or > 0.6, if the concurrent DAS28 was ≥ 3.2. Cox regression analysis was used to identify baseline predictors of flares. Of the 1.717 patients with RA, 566 (33.0%) experienced flares during the 2-year study period. An analysis of baseline characteristics of flare and non-flare groups revealed that more women and non-smokers were present in the flare group than in the non-flare group; the flare group also had higher scores on physician’s and patient’s pain and fatigue visual analogue scales (VAS) and the health assessment questionnaire (HAQ). In a multivariate analysis, physician’s VAS score, hemoglobin level, and HAQ score were significant predictors of flares. A high physician’s VAS score, low hemoglobin, and high HAQ score at baseline were significant predictors of flares in patients with RA who exhibited LDA.

Highlights

  • The treatment of rheumatoid arthritis (RA) should target remission or low disease activity (LDA) in every patient [1]

  • The EQ-5D score was higher in the non-flare group, while the health assessment questionnaire (HAQ) score was higher in the flare group

  • This study investigated the predictors of flare in patients with RA who exhibited LDA for 2 years using data from a large cohort

Read more

Summary

Introduction

The treatment of rheumatoid arthritis (RA) should target remission or low disease activity (LDA) in every patient [1]. The ability to predict flares when patients reach remission or LDA could facilitate decisions regarding treatment maintenance or reduction. Bechman et al evaluated predictors for flare in 97 RA patients who tapered tumor necrosis inhibitors after they reached sustained LDA [4]. They found baseline DAS28 and mental health status were predictors for flare. In a recent study of 152 RA patients with LDA, health assessment questionnaire (HAQ) was a significant predictor for flare [6]. They were relatively small-sized and short-term observation studies. Using nationwide cohort data, this study investigated predictors of flares in patients with RA who exhibited established LDA and the effects of flares on clinical outcomes in those patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call